BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 25866775)

  • 1. Blood brain barrier: a challenge for effectual therapy of brain tumors.
    Bhowmik A; Khan R; Ghosh MK
    Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
    Arvanitis CD; Ferraro GB; Jain RK
    Nat Rev Cancer; 2020 Jan; 20(1):26-41. PubMed ID: 31601988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
    On NH; Miller DW
    Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery systems for brain tumor therapy.
    Rautioa J; Chikhale PJ
    Curr Pharm Des; 2004; 10(12):1341-53. PubMed ID: 15134485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
    Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
    Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
    Wu L; Li X; Janagam DR; Lowe TL
    Pharm Res; 2014 Mar; 31(3):531-40. PubMed ID: 23996470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
    Parrish KE; Sarkaria JN; Elmquist WF
    Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.
    Haumann R; Videira JC; Kaspers GJL; van Vuurden DG; Hulleman E
    CNS Drugs; 2020 Nov; 34(11):1121-1131. PubMed ID: 32965590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
    Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
    Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
    Wang Z; Sun H; Yakisich JS
    Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
    Zhang F; Xu CL; Liu CM
    Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.
    Papademetriou IT; Porter T
    Ther Deliv; 2015; 6(8):989-1016. PubMed ID: 26488496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
    Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.